rfk tirzepatide fda indications The peptide regulatory landscape in 2026 is in active flux. After the placed rfk tirzepatide Q&A: Understanding the

According to Ricardo Correa, the endocrinology fellowship director at the University of Arizona College of Medicine , compound pharmacies "are probably using the same active pharmacological part [semaglutide], but when you combine things and you add different excipients, the effectivenessif you don't measure that in a randomized controlled trialwill not be the same." "I can tell you, the consensus amongst legitimate practicing obesity endocrinology specialists is to avoid this, because it's just too much unknown," Nadolsky said

while Wegovy helps suppress the appetite , a person still needs to choose foods wisely

thus, our findings on GLP-1-related psychiatric AEs need to be confirmed by large prospective studies

As weight decreases, insulin resistance often improves

Explain that although the medication has not been shown to cause thyroid disease, it may impact thyroid hormone levels or interact with thyroid medications